ImageneBio (IMA) Other Working Capital Changes (2020 - 2025)
ImageneBio's (IMA) quarterly Other Working Capital Changes came in at -$2.6 million in Q3 2025, down 302.0% year-over-year from $1.3 million in Q3 2024, and down 159.64% quarter-over-quarter from $4.4 million in Q2 2025.
Analysis
ImageneBio (IMA) Other Working Capital Changes (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$2.6 million for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 302.0% year-over-year to -$2.6 million; the TTM figure through Sep 2025 stood at $700000.0 (up 163.81% YoY), while the FY2024 annual figure was -$3.2 million, down 54.14% from the prior year.
- Other Working Capital Changes came in at -$2.6 million for Q3 2025 at ImageneBio, down from $4.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$381000.0 in Q2 2022 to a low of -$20.2 million in Q4 2021.
- Average Other Working Capital Changes over 4 years is -$4.3 million, with a median of -$3.5 million recorded in 2021.
- The largest YoY upside for Other Working Capital Changes was 919.47% in 2021 against a maximum downside of 3886.36% in 2021.
- Over 5 years, Other Working Capital Changes stood at -$1.7 million in 2021, then surged by 66.75% to -$554000.0 in 2022, then slumped by 36.1% to -$754000.0 in 2023, then sank by 281.17% to -$2.9 million in 2024, then grew by 8.42% to -$2.6 million in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.6 million in Q3 2025, $4.4 million in Q2 2025, and $1.8 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -650,000.00 |
| Mar 31, 2025 | -650,000.00 |
| Dec 31, 2023 | -659,000.00 |
| Dec 31, 2023 | -659,000.00 |
| Sep 30, 2023 | -1.19 Mn |
| Sep 30, 2023 | -1.19 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | -5.31 Mn |
| Mar 31, 2023 | -5.31 Mn |
| Dec 31, 2022 | -5.45 Mn |
| Dec 31, 2022 | -5.45 Mn |
| Sep 30, 2022 | -6.40 Mn |
| Sep 30, 2022 | -6.40 Mn |
| Jun 30, 2022 | -381,000.00 |
| Jun 30, 2022 | -381,000.00 |
| Mar 31, 2022 | -3.38 Mn |
| Mar 31, 2022 | -3.38 Mn |
| Dec 31, 2021 | -20.22 Mn |
| Dec 31, 2021 | -20.22 Mn |